Cardiovascular models are moving to the bedside
Computational modeling can help fill gaps in how we develop and review new drugs and devices
Decades of steady progress in pharmacogenetics have unearthed hundreds of associations between genes and drug response. But the field has to solve some theoretical and practical issues before it can deliver on the promise of personalized drug therapy.
How researchers are combining disparate data types and simulating systems that contain many different moving parts
A recognition of biocomputing's successes and a prediction of what's to come
Modelers should take the lead.